ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

HALO Halozyme Therapeutics Incorporated

38.88
0.42 (1.09%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 102M117.28M152.37M208.98M181.5M162.14M221.04M216.03M
Operating Income 56.53M75.67M34.06M63.19M74.51M53.8M94.46M88.28M
Pre Tax Income 54.81M74.41M30.01M73.71M70.79M52.24M93.16M101.76M
Net Income 66.77M60.11M22.69M61.63M57.7M39.62M74.75M81.84M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT 56.53M76.17M33.61M60.93M74.51M53.8M94.46M88.28M
EBITDA 57.31M76.45M46.61M92.4M81.62M74.26M115.09M111.36M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 146.69M316.61M151.86M195.99M267.59M443.31M660.12M829.25M
Operating Income -83.21M81M-69.33M-67.61M144.26M275.9M267.53M337.57M
Pre Tax Income -101.86M61.61M-79.79M-72.25M129.3M248.52M248.92M348.33M
Net Income -103.02M62.97M-80.33M-72.24M129.09M402.71M202.13M281.59M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.7480.417-0.525-0.4990.9012.7641.412.007
EBIT -83.21M81M-61.75M-60.62M149.68M254.94M264.82M337.57M
EBITDA -80.8M83.16M-66.94M-63.54M147.54M278.9M317.17M422.43M

Your Recent History

Delayed Upgrade Clock